U.S. markets close in 1 hour 11 minutes

NeutriSci International Inc. (NRXCF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.13690.0000 (0.00%)
As of 3:09PM EDT. Market open.
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close0.1369
Open0.1369
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.1369 - 0.1369
52 Week Range0.0365 - 0.2666
Volume300
Avg. Volume12,889
Market Cap20.168M
Beta (5Y Monthly)2.52
PE Ratio (TTM)N/A
EPS (TTM)-0.0110
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
View more
  • Neutrisci Announces Successful Completion of Phase 1 R&D Development of a Cannabinol Product
    ACCESSWIRE

    Neutrisci Announces Successful Completion of Phase 1 R&D Development of a Cannabinol Product

    VANCOUVER, BC / ACCESSWIRE / May 10, 2021 / NeutriSci International Inc. ("NeutriSci" or the "Company") (TSX-V: NU, OTCQB: NRXCF, FRANKFURT: 1N9), an innovative technology company developing products for the nutraceutical industry, is pleased to announce the Phase 1 R&D completion of a newly developed Cannabinol (CBN) product for the US marketplace.

  • Neutrisci Receives Additional Order for Japanese Market
    ACCESSWIRE

    Neutrisci Receives Additional Order for Japanese Market

    VANCOUVER, BC / ACCESSWIRE / May 3, 2021 / NeutriSci International Inc. ("NeutriSci" or the "Company") (TSXV:NU)(OTCQB:NRXCF)(FSE:1N9), an innovative technology company developing products for the nutraceutical industry, is pleased to announce that Tabletz LLC.

  • Neutrisci Announces New State-Of-The-Art Production and Research Facility in Las Vegas, Nevada, USA
    ACCESSWIRE

    Neutrisci Announces New State-Of-The-Art Production and Research Facility in Las Vegas, Nevada, USA

    VANCOUVER, BC / ACCESSWIRE / March 18, 2021 / NeutriSci International Inc. ("NeutriSci" or the "Company") (TSX-V:NU)(OTCQB:NRXCF)(FRANKFURT:1N9), an innovative technology company developing products for the nutraceutical industry, is very pleased to announce the completion of its newly dedicated production line and research lab in Las Vegas, Nevada.